Support Cancer Research Funding: Sponsor a Scientist
Sponsor a Scientist
Funding OCRA’s scientific research initiatives is one of the most powerful ways to support our life-saving work.
Contribute to Groundbreaking Research
Our Partners in Science program allows you to directly contribute to groundbreaking research aimed at preventing ovarian and related gynecologic cancers, developing better, more effective treatments, and ultimately finding a cure.
Program Details
The OCRA Partners in Science program offers donors a unique opportunity to sponsor specific scientists based on personalized criteria, fostering a meaningful connection between donors and researchers. The minimum contribution is $20,000.
-
Donors choose scientists to sponsor based on factors like geographic location, institution, or area of study. Sponsored researchers are selected from projects reviewed and approved annually by OCRA’s Scientific Advisory Committee (SAC).
-
Donors can review detailed grant information, including project summaries, abstracts, or full proposals. There’s ongoing communication between donors and researchers, with possibilities for personalized lab tours. Donors also receive regular updates on research progress, final summaries, annual reports, and publications resulting from the research.
-
Donors can sponsor multiple investigators depending on the contribution amount or co-sponsor a research project with others.
-
The program is open to individual donors, private family foundations, organizations, community events, and groups of friends or relatives supporting research on behalf of a loved one. OCRA staff provide guidance throughout the selection process, ensuring a meaningful and personal experience.
-
Donors’ support is acknowledged on the OCRA website, and grants can be named in honor or in memory of a loved one.
Partners in Science Donors
Become a Partner in Science
To learn more about becoming an OCRA Partner in Science, please contact Jon Zeidman, Chief Development Officer, at jzeidman@ocrahope.org or 212-268-1002.
Related Topics
OCRA-Funded Study Provides Clear New Evidence That Opportunistic Salpingectomy Drastically Reduces Risk of Ovarian Cancer
A new study published February 2 in JAMA Network Open provides the clearest evidence to date that opportunistic salpingectomy—the removal of the fallopian tubes during another gynecologic surgery—can dramatically reduce the risk of ovarian cancer. Led by a B.C.-based international collaboration known as the Ovarian Cancer Observatory, the study found that people who underwent opportunistic … Continued
(Webinar) – Ask the Experts: Gynecologic Sarcoma
Watch Now: Ask the Experts Webinar on Gynecologic Sarcoma On January 28, 2026, Ovarian Cancer Research Alliance (OCRA) hosted a live Ask the Experts: Gynecologic Sarcoma webinar with Matthew Hemming, MD, PhD. Moderated by Liza Lundgren, LCSW, OCRA’s Director of Education, this free session featured a live discussion and audience Q&A focused on gynecologic sarcoma research, … Continued
Action Alert: Urge Congress to Pass Final Bill on Cancer Research Funding and Early Detection
The Congressional Appropriations Committees have released a combined FY2026 Defense/Labor, Health and Human Services bill—and it includes several critical investments and policy provisions that would significantly strengthen the federal response to ovarian and other gynecologic cancers. This bill represents meaningful progress for our community, but it is not final. Congress must act swiftly to advance and … Continued